Alaunos Therapeutics, Inc.
TCRT
$4.29
$0.2947.36%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -70.76% | -35.18% | -31.67% | -40.58% | -31.62% |
Total Receivables | -60.00% | -- | -- | 300.00% | 0.00% |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -55.03% | -11.14% | -15.56% | 16.92% | -13.97% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | -61.27% | -22.39% | -24.11% | -22.51% | -26.92% |
|
|||||
Total Current Assets | -61.27% | -22.39% | -24.11% | -22.51% | -26.92% |
Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | -23.05% | -22.39% | -24.11% | -22.51% | -26.94% |
|
|||||
Total Accounts Payable | 61.05% | 12.66% | 25.48% | -38.86% | -3.08% |
Total Accrued Expenses | 31.25% | -52.17% | -32.10% | -15.71% | -52.01% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | 53.47% | -16.22% | -8.93% | -26.85% | -36.61% |
|
|||||
Total Current Liabilities | 53.47% | -16.22% | -8.93% | -26.85% | -36.61% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 53.47% | -16.22% | -8.93% | -26.85% | -36.61% |
|
|||||
Common Stock & APIC | 0.01% | 0.01% | 0.01% | 0.01% | 0.02% |
Retained Earnings | -0.12% | -0.08% | -0.12% | -0.12% | -0.18% |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | -48.72% | -24.27% | -27.76% | -21.39% | -23.94% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -48.72% | -24.27% | -27.76% | -21.39% | -23.94% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -48.72% | -24.27% | -27.76% | -21.39% | -23.94% |
|